What's new
Newsletters "UptoDate" of BASG/AGES MEA are published monthly and contain the latest articles from the last month (link to subscription page).
For the RSS feed with daily notification of updates, use the link: RSS feed to "what's new".
Searched for "active".
messages in brief
|
26/07/2019
Situation in Austria Imurek-50 mg Film-Coated Tablets are currently temporarily unavailable due to increased demand beyond national borders, and associated capacity constraints at the manufacturer. This information is publicly available on the…
23/07/2019
address of the manufacturer(s) of the dosage form***) |_| In the CPP only active substances should be stated |_| In the CPP active substances and excipients should be stated |_| The medicinal product is
Referenced at:
03/07/2019
Competent Authority the notification of approval by the BMASGKFurther information on harmonization activities for clinical trials with genetically modified organismsInformation der Europäischen can be found [...] stoppage of the trial not envisaged in the approved protocol and where there is an intention to resume activities. A temporary halt can be a substantial amendment (IV.1) or part of an urgent safety measure (IV [...] means a biological medicinal product which has the following characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic acid used in or administered to human
Referenced at:
03/07/2019
Competent Authority the notification of approval by the BMASGKFurther information on harmonization activities for clinical trials with genetically modified organismsInformation der Europäischen can be found [...] stoppage of the trial not envisaged in the approved protocol and where there is an intention to resume activities. A temporary halt can be a substantial amendment (IV.1) or part of an urgent safety measure (IV [...] means a biological medicinal product which has the following characteristics: (a) it contains an active substance which contains or consists of a recombinant nucleic acid used in or administered to human
Referenced at:
13/05/2019
Symptoms associated with Zika virus (ZIKV) infection are generally mild and most people who become infected do not develop any symptoms. However, since the 2015‒2017 epidemic in the Americas, ZIKVhas been recognised asbeingassociated with severe neurological disorders
Referenced at:
21/02/2019
Zusammenfassung der jährlichen Berichterstattung über ernste unerwünschte Reaktionen und Zwischenfälle bei Blut und Blutbestandteilen (2017) - Bericht nur auf englisch verfügbar
Referenced at:
Safety warnings
|
messages in brief
|
14/02/2019
During the transitional phase, strict limits are already in place for these impurities.
Safety warnings
|
Medicines
|
14/02/2019
During the transitional phase, strict limits are already in place for these impurities.
messages in brief
|
04/02/2019
The EMA published a revision of the “Guideline on the environmental risk assessment (ERA) of human medicines” on 30 November 2018. The guideline is now open for public consultation until 30 June 2019. The purpose of the ‚Guideline on Environmental…
Safety warnings
|
Medicines
|
21/12/2018
No acute danger, all packages available in Austria have already been recalled by BASG.